Amended Statement of Ownership (sc 13g/a)
12 February 2013 - 7:27AM
Edgar (US Regulatory)
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the
Securities Exchange Act of 1934
(Amendment No.: 2
)*
Name
of issuer: PSS World Medical Inc
Title
of Class of Securities: Common Stock
CUSIP
Number: 69366A100
Date
of Event Which Requires Filing of this Statement:
December 31, 2012
Check
the appropriate box to designate the rule pursuant to which this Schedule is
filed:
(X)
Rule 13d-1(b)
(
) Rule 13d-1(c)
(
) Rule 13d-1(d)
*The
remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to
be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
(Continued
on the following page(s))
13G
CUSIP
No.: 69366A100
1. NAME
OF REPORTING PERSON
S.S.
OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The
Vanguard Group - 23-1945930
2. CHECK
THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP
3. SEC
USE ONLY
4. CITIZENSHIP
OF PLACE OF ORGANIZATION
Pennsylvania
(For
questions 5-8, report the number of shares beneficially owned by each reporting
person with:)
5.
SOLE VOTING POWER
70,459
6.
SHARED VOTING POWER
7. SOLE
DISPOSITIVE POWER
2,960,976
8. SHARED
DISPOSITIVE POWER
68,459
9. AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,029,435
10. CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
N/A
11. PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.02%
12. TYPE
OF REPORTING PERSON
IA
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the
Securities Act of 1934
Check
the following [line] if a fee is being paid with this statement N/A
Item
1(a) - Name of Issuer:
PSS
World Medical Inc
Item
1(b) - Address of Issuer's Principal Executive Offices:
4345
SOUTHPOINT BLVD.
JACKSONVILLE,
FLORIDA 32216
Item
2(a) - Name of Person Filing:
The
Vanguard Group - 23-1945930
Item
2(b) – Address of Principal Business Office or, if none, residence:
100 Vanguard Blvd.
Malvern, PA 19355
Item
2(c) – Citizenship:
Pennsylvania
Item
2(d) - Title of Class of Securities:
Common
Stock
Item
2(e) - CUSIP Number
69366A100
Item
3 - Type of Filing:
This
statement is being filed pursuant to Rule 13d-1. An investment
adviser in accordance with §240.13d-1(b)(1)(ii)(E).
Item
4 - Ownership:
(a) Amount Beneficially Owned:
3,029,435
(b) Percent of Class:
6.02%
(c) Number
of shares as to which such person has:
(i) sole
power to vote or direct to vote: 70,459
(ii) shared
power to vote or direct to vote:
(iii) sole
power to dispose of or to direct the disposition of: 2,960,976
(iv) shared
power to dispose or to direct the disposition of: 68,459
Comments:
Item
5 - Ownership of Five Percent or Less of a Class:
Not
Applicable
Item
6 - Ownership of More Than Five Percent on Behalf of Another Person:
Not
applicable
Item
7 - Identification and Classification of the Subsidiary Which Acquired The
Security Being Reported on by the Parent Holding Company
:
See
Attached Appendix A
Item
8 - Identification and Classification of Members of Group:
Not
applicable
Item
9 - Notice of Dissolution of Group:
Not
applicable
Item
10 - Certification:
By
signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired in the ordinary course of business
and were not acquired for the purpose of and do not have the effect of changing
or influencing the control of the issuer of such securities and were not
acquired in connection with or as a participant in any transaction having such
purpose or effect.
Signature
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and correct.
Date: 02/07/13
By
/s/ F.
William McNabb III*
F. William
McNabb III
President and
Chief Executive Officer
*By:
/s/ Glenn Booraem
Glenn Booraem,
pursuant to a Power of Attorney filed January 29, 2010, see File Number
005-81485, Incorporated by Reference
Appendix
A
Vanguard
Fiduciary Trust Company ("VFTC"), a wholly-owned subsidiary of The
Vanguard Group, Inc., is the beneficial owner of 68,459 shares or .13% of the
Common Stock outstanding of the Company as a result of its serving as
investment manager of collective trust accounts.
Vanguard
Investments Australia, Ltd. ("VIA"), a wholly-owned subsidiary of The
Vanguard Group, Inc., is the beneficial owner of 2,000 shares or
.00% of the Common Stock outstanding of the Company
as a result of its serving as investment manager of Australian investment
offerings.
By
/s/ F.
William McNabb III*
F. William
McNabb III
President and
Chief Executive Officer
*By:
/s/ Glenn Booraem
Glenn Booraem,
pursuant to a Power of Attorney filed on January 29, 2010, see File Number
005-81485, Incorporated by Reference
PSS World Medical (NASDAQ:PSSI)
Historical Stock Chart
From Oct 2024 to Nov 2024
PSS World Medical (NASDAQ:PSSI)
Historical Stock Chart
From Nov 2023 to Nov 2024
